Rice Partnership LLC Sells 1,738 Shares of Danaher Corporation $DHR

Key Points

• Rice Partnership LLC reduced its stake in Danaher Corporation by 6.0%, selling 1,738 shares, and now holds 27,330 shares valued at approximately $5.4 million.
• Danaher reported $1.80 earnings per share in its last quarterly earnings, surpassing analyst estimates of $1.64, with a revenue of $5.94 billion, a 3.4% increase year-over-year.
• The company declared a quarterly dividend of $0.32 per share, payable on October 31st, representing an annual yield of 0.6%.

Rice Partnership LLC cut its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 6.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,330 shares of the conglomerate's stock after selling 1,738 shares during the quarter. Danaher comprises approximately 0.9% of Rice Partnership LLC's portfolio, making the stock its 29th biggest position. Rice Partnership LLC's holdings in Danaher were worth $5,399,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of DHR. Patriot Financial Group Insurance Agency LLC increased its holdings in shares of Danaher by 7.2% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 1,067 shares of the conglomerate's stock valued at $219,000 after acquiring an additional 72 shares in the last quarter. Portside Wealth Group LLC increased its holdings in shares of Danaher by 12.4% during the first quarter. Portside Wealth Group LLC now owns 1,004 shares of the conglomerate's stock valued at $206,000 after acquiring an additional 111 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in Danaher by 12.0% in the 1st quarter. Farther Finance Advisors LLC now owns 8,719 shares of the conglomerate's stock worth $1,747,000 after buying an additional 935 shares in the last quarter. GAMMA Investing LLC increased its holdings in Danaher by 22.2% in the 1st quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate's stock worth $1,871,000 after buying an additional 1,660 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its holdings in Danaher by 1.0% in the 1st quarter. Assenagon Asset Management S.A. now owns 20,634 shares of the conglomerate's stock worth $4,230,000 after buying an additional 203 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Down 1.7%

DHR stock opened at $205.13 on Thursday. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.41. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The stock has a market cap of $146.88 billion, a P/E ratio of 43.64, a PEG ratio of 2.97 and a beta of 0.77. The business's 50-day moving average price is $200.41 and its 200-day moving average price is $197.38.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. During the same period in the previous year, the firm earned $1.72 EPS. The business's quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher's payout ratio is currently 27.23%.

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of the business's stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 11.10% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Bank of America reduced their price objective on Danaher from $230.00 to $220.00 and set a "buy" rating for the company in a report on Monday, September 22nd. Robert W. Baird lifted their price objective on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday, July 18th. Redburn Partners set a $220.00 price objective on Danaher in a report on Wednesday. Royal Bank Of Canada set a $241.00 price objective on Danaher in a report on Tuesday, September 2nd. Finally, Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Seventeen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $244.60.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.